Extra Super Levitra: Unregulated Combination Therapy for Erectile Dysfunction - Evidence-Based Review
| Dosaggio del prodotto: 40mg+60mg | |||
|---|---|---|---|
| Confezione (n.) | Per compresse | Prezzo | Acquista |
| 30 | €2.82 | €84.54 (0%) | 🛒 Aggiungi al carrello |
| 40 | €2.73 | €112.73 €109.31 (3%) | 🛒 Aggiungi al carrello |
| 60 | €2.65 | €169.09 €158.84 (6%) | 🛒 Aggiungi al carrello |
| 120 | €2.55 | €338.18 €306.58 (9%) | 🛒 Aggiungi al carrello |
| 180 | €2.51
Migliore per compresse | €507.27 €452.61 (11%) | 🛒 Aggiungi al carrello |
Prodotti simili
Product Description
The product in question, often marketed under names like “Extra Super Levitra,” presents a significant clinical and regulatory concern. It is not a single, approved pharmaceutical entity but rather an unregulated dietary supplement or, in some cases, an illicitly marketed product that purports to combine the active ingredients of two distinct prescription phosphodiesterase type 5 (PDE5) inhibitors: vardenafil (the active component in Levitra) and sildenafil (the active component in Viagra). These are frequently combined with other compounds like dapoxetine, a selective serotonin reuptake inhibitor used off-label for premature ejaculation. The “Extra Super” moniker is a marketing term with no medical meaning, designed to imply enhanced potency. These products are typically sold online without a prescription, bypassing standard pharmaceutical quality control, regulatory oversight, and medical consultation. Their use carries substantial, documented risks due to unverified composition, incorrect dosing, and the inherent dangers of combining potent vasoactive drugs.
1. Introduction: What is Extra Super Levitra? Its Role in Modern Medicine
In the landscape of men’s health, particularly for erectile dysfunction (ED), the proliferation of online pharmacies has led to the emergence of products with names like Extra Super Levitra. It is crucial for healthcare professionals and informed consumers to understand that this is not a novel, researched drug approved by any major regulatory body like the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), or Health Canada. Instead, Extra Super Levitra falls into a category of unregulated, often adulterated, combination products.
Its purported “role” is to address both erectile dysfunction and premature ejaculation simultaneously by mashing together active pharmaceutical ingredients (APIs) from separate, prescription-only medications. This approach bypasses the essential medical steps of diagnosis, appropriate monotherapy selection, dose titration, and safety screening. The medical application of such a combination, if ever deemed appropriate, would require rigorous Phase III clinical trials and strict post-marketing surveillance—none of which exist for these off-market products. Their significance is unfortunately negative, representing a public health risk rather than a therapeutic advance.
2. Key Components and Bioavailability of Extra Super Levitra
The composition of Extra Super Levitra is inconsistent and unverified. Chemical analyses by regulatory agencies (e.g., FDA laboratory alerts) repeatedly find that these products contain varying, often high doses of multiple PDE5 inhibitors.
Primary Suspect APIs:
- Vardenafil: The namesake component, typically dosed at 20mg in legitimate Levitra. Found in these products in unknown quantities.
- Sildenafil: The active ingredient in Viagra, often dosed at 50mg or 100mg. Its co-administration with vardenafil is pharmacologically redundant and increases adverse effect risk exponentially.
- Dapoxetine: A short-acting SSRI used in some countries for premature ejaculation. Its inclusion aims to target a second condition, creating a “two-in-one” product.
Critical Bioavailability and Safety Issues: The bioavailability and pharmacokinetics of these individual drugs are well-studied in isolation. Sildenafil has an onset of ~30-60 minutes and a half-life of ~4 hours. Vardenafil is similar. Combining them does not create a synergistic “super” effect; it creates an unpredictable plasma concentration curve, dramatically increasing the risk of prolonged and severe hypotension. Furthermore, these products often contain incorrect stereoisomers of the APIs (e.g., thio-sildenafil) or related analogues not intended for human consumption, with completely unknown absorption and metabolism profiles. There is no “superior form” here—only dangerous contamination.
3. Mechanism of Action of Extra Super Levitra: Scientific Substantiation
To understand the danger, one must understand the mechanism of action. Both sildenafil and vardenafil are competitive inhibitors of phosphodiesterase type 5 (PDE5). PDE5 breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. By inhibiting PDE5, cGMP levels increase, leading to smooth muscle relaxation, vasodilation, and increased blood flow, which facilitates an erection.
How Extra Super Levitra “works” is simply by delivering a double or even triple dose of PDE5 inhibition. This is not a refined effect on the body; it is a pharmacological sledgehammer. The scientific research on PDE5 inhibitors clearly demonstrates a dose-dependent increase in efficacy and adverse effects. Combining two inhibitors at full or partial doses pushes the patient far beyond the therapeutic window of either drug alone, massively amplifying vasodilatory effects not just in the penis, but systemically. This can lead to dangerous drops in blood pressure, especially in the presence of nitrates.
4. Indications for Use: What is Extra Super Levitra Effective For?
There are no approved indications for use for a product called Extra Super Levitra. Its marketing targets two conditions:
Extra Super Levitra for Erectile Dysfunction (ED)
It provides PDE5 inhibition, so it may induce erection in some men. However, its effectiveness is unreliable and unsafe compared to a properly prescribed, single-agent therapy at a correct, individualized dose. The risk-benefit ratio is profoundly negative.
Extra Super Levitra for Premature Ejaculation (PE)
This is based on the potential inclusion of dapoxetine. However, dapoxetine requires specific timing (1-3 hours before intercourse) and its own dose adjustment. Combining it with PDE5 inhibitors complicates its side effect profile (nausea, dizziness, drowsiness) and has not been properly studied in this clandestine formulation.
For Treatment of Concurrent ED and PE
This is the marketed “niche.” Responsible medicine involves diagnosing the primary concern, treating it, and then assessing the other. A combined pill removes all nuance and patient-specific care, offering a one-size-fits-all solution to a complex biopsychosocial problem. It is not effective for safe, long-term management.
5. Instructions for Use: Dosage and Course of Administration
There are no safe instructions for use or dosage guidelines for an unregulated product. Labels are often falsified. A typical illicit pill might claim to contain “Vardenafil 20mg + Sildenafil 50mg + Dapoxetine 60mg,” but analyses show wild variations—one pill may have none of the stated drug, the next may contain triple the amount.
If one were to consider the theoretical components:
| Condition Targeted | Purported Dose (Unverified) | Purported Timing | Critical Risk |
|---|---|---|---|
| ED & PE | 1 tablet | 30-60 min before activity | Extreme. Unpredictable drug levels, severe hypotension, interaction with nitrates/food/other meds. |
| How to take is irrelevant, as the course of administration should be zero. The only appropriate instruction is to discard the product and consult a physician. |
6. Contraindications and Drug Interactions of Extra Super Levitra
The contraindications list is extensive and absolute. This product should never be used by patients:
- Using any form of organic nitrates (e.g., nitroglycerin, isosorbide) for angina. This combination can cause fatal hypotension.
- With severe cardiovascular disease (unstable angina, recent MI, heart failure).
- With significant hepatic or severe renal impairment.
- With hereditary retinal disorders (e.g., retinitis pigmentosa).
- During pregnancy: Not applicable to the patient, but underscores the lack of formal testing.
Drug interactions are numerous and dangerous:
- Nitrates: Absolute contraindication. Life-threatening.
- Alpha-blockers (e.g., doxazosin, tamsulosin): Profoundly additive hypotensive effect.
- Other antihypertensives: Potentiated blood pressure lowering.
- Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, erythromycin): Can skyrocket systemic levels of the PDE5 inhibitors, leading to toxicity.
- Other PDE5 inhibitors: Obviously, but this product is the interaction.
- Alcohol: Can increase risk of hypotension, dizziness, and tachycardia.
Side effects are amplified and may include severe headache, flushing, dyspepsia, nasal congestion, visual disturbances (non-arteritic anterior ischemic optic neuropathy - NAION), priapism, profound hypotension, syncope, and myocardial infarction.
7. Clinical Studies and Evidence Base for Extra Super Levitra
There are no legitimate clinical studies on a product named Extra Super Levitra. The scientific evidence base is comprised entirely of:
- Independent Laboratory Analyses: Reports from the FDA, MHRA (UK), and TGA (Australia) documenting adulteration with undeclared pharmaceuticals.
- Case Reports in Medical Literature: Documented incidents of adverse events, including severe hypotension, priapism requiring intervention, and visual loss, linked to consumption of similar illicit combination products.
- Studies on Adulterated Supplements: Systematic reviews showing a high percentage of “herbal” or “natural” ED supplements are contaminated with sildenafil, tadalafil, or their analogues.
The effectiveness from a regulatory and evidence-based medicine standpoint is zero. The risk profile, however, is well-documented and high. Any physician reviews would be condemnatory, focusing on the dangers posed to public health.
8. Comparing Extra Super Levitra with Similar Products and Choosing a Quality Product
When comparing Extra Super Levitra with similar products (e.g., “Super Kamagra,” “Extra Super P-Force”), the comparison is between different unregulated, dangerous products. The question “which Extra Super Levitra is better?” is meaningless, as quality control is absent. One batch may be inert, the next lethally potent.
How to choose a quality product for ED or PE:
- Consult a Licensed Physician: This is non-negotiable. ED can be a marker of cardiovascular disease.
- Obtain a Legitimate Prescription: For a single, approved, pure pharmaceutical agent (e.g., sildenafil, tadalafil, vardenafil, or avanafil).
- Source from a Licensed Pharmacy: Either a brick-and-mortar pharmacy or a verified, accredited online pharmacy that requires a valid prescription.
- Avoid Any Product that: Promises a “super” combination, is sold without a prescription, has prices that seem too good to be true, or uses marketing copy instead of official prescribing information.
9. Frequently Asked Questions (FAQ) about Extra Super Levitra
Is Extra Super Levitra a safe and approved medication?
No. It is not approved by any major regulatory health authority. It is an unregulated, adulterated product and is not safe for consumption.
What is the recommended course of Extra Super Levitra to achieve results?
There is no recommended course. Medical advice is to avoid it entirely and seek a proper medical evaluation for erectile dysfunction or premature ejaculation.
Can Extra Super Levitra be combined with heart medication like nitrates?
Absolutely not. The combination with nitrates or certain blood pressure medications can cause a severe, potentially fatal drop in blood pressure.
How long do the effects of Extra Super Levitra last?
The duration is unpredictable due to unknown and variable composition. It could last far longer than intended, increasing the risk of adverse events.
Are there natural alternatives to Extra Super Levitra?
Be cautious. Many “natural” ED supplements have been found to contain the same hidden prescription drugs. The only evidence-based approach is a medical consultation to address the root cause.
10. Conclusion: Validity of Extra Super Levitra Use in Clinical Practice
The validity of Extra Super Levitra use in clinical practice is zero. From an evidence-based perspective, it represents a significant and documented patient safety risk. Its use undermines the principles of ethical medicine, which prioritize accurate diagnosis, individualized treatment, and monitored safety.
The risk-benefit profile is unequivocally negative. The potential for severe cardiovascular events, dangerous drug interactions, and exposure to unknown contaminants far outweighs any potential, unreliable benefit. The final, expert recommendation is clear: Healthcare professionals must actively warn patients about these products, and patients must be educated to steer clear of them and pursue legitimate medical pathways for managing sexual health concerns.
Personal Anecdote & Clinical Experience:
Let me tell you about a case that really cemented my view on these combination products. It wasn’t even my patient initially; he was admitted to cardiology with syncope. 62-year-old guy, let’s call him Robert, history of well-controlled hypertension on amlodipine. He’d been too embarrassed to talk to his GP about his ED, so he did what so many do—Googled it and ordered “Extra Super Levitra” from a site that looked legit. Took one pill. Felt dizzy an hour later, stood up, and collapsed. His wife found him. BP in the ER was 85/50. No nitrate use, thankfully, but the amlodipine was enough. The cardiology fellow called me in because the tox screen was odd—it showed metabolites consistent with both sildenafil and vardenafil.
When I sat with Robert, he showed me the blister pack. It looked professional, had a fake manufacturer logo, even a batch number. He said, “It said it was stronger, so I thought it would work better.” That’s the marketing hook, right? “Extra Super.” We spent a long time talking. I explained that his heart was basically working against a double-barrel vasodilator. The scary part was the unknown dose. Was it 20mg of each? 40? We’ll never know. He recovered, but it was a wake-up call for him and a teaching moment for the residents.
This stuff creates a nightmare for us. In our clinic, we’ve had the internal debates. Some of the younger guys, more tech-savvy, argue about harm reduction—“If they’re going to buy it online anyway, maybe we should at least test their pills?” But our senior pharmacologist, Dr. Al-Masri, shut that down hard in a team meeting. “You cannot,” she said, “lend any legitimacy to an uncontrolled substance. Your duty is to say no, explain why, and offer the safe path.” She was right. Testing one pill doesn’t guarantee the next in the pack is the same.
We see the pattern: the patients who use these are often the ones most afraid of the “judgment” of a doctor’s visit. They want a simple, powerful solution. But medicine isn’t like that. I remember another patient, Mark, early 50s, diabetic. He’d been using a similar combo pill for months. When he finally came in, his HbA1c was terrible. The ED was his canary in the coal mine, and by self-treating with a black-market pill, he’d ignored the signal for over a year. We got his sugars under control, started him on a proper, low-dose PDE5 inhibitor, and the efficacy was better with zero side effects. He said the illicit pill gave him a pounding headache and a blue tinge to his vision he’d just written off as “the price to pay.”
The development struggle here isn’t in a lab; it’s in the consultation room. It’s fighting against slick online marketing and patient shame. The unexpected finding for me hasn’t been biochemical—it’s been realizing that part of our job is to be better marketers of safe, legitimate care than the shadowy online pharmacies are of their dangerous wares. We have to sell trust. And that starts with being brutally honest about products like Extra Super Levitra. Follow-up with these patients is key. When they see that a real prescription works more reliably and safely, they become our best advocates. Robert actually asked for pamphlets to show his golf buddies. “Tell them what happened to me,” he said. Real-world observation trumps a thousand online reviews.
More info:
Popular Products
Abhigra
Let me tell you about Abhigra. It’s not just another turmeric supplement that came across my desk. I first encountered it about three years ago when a particularly stubborn patient, a 62-year-old retired carpenter named Robert with osteoarthritis in both knees and low-grade metabolic syndrome, was desperate to avoid escalating his NSAID use due to borderline renal function. He’d tried everything – glucosamine, chondroitin, standard curcumin – with what he called “placebo-level relief.
Apcalis SX Oral Jelly: Trattamento Rapido e Discreto per la Disfunzione Erettile - Monografia Basata sull'Evidenza
Prima di entrare nel dettaglio del documento strutturato, è fondamentale descrivere cos’è realmente questo prodotto. L’Apcalis SX Oral Jelly rappresenta un adattamento farmaceutico significativo del principio attivo Tadalafil, un inibitore della fosfodiesterasi di tipo 5 (PDE5) di seconda generazione. A differenza delle compresse tradizionali, si presenta in una formulazione gelificata orale, monodose, con diversi aromi. La sua caratteristica distintiva non è solo la via di somministrazione, ma la farmacocinetica che ne deriva: un assorbimento sublinguale e buccale più rapido, bypassando parzialmente il sistema portale epatico, il che si traduce in un inizio d’azione potenzialmente più veloce rispetto alla compressa standard.
Avana: Supporto Neurologico per Stress e Ansia - Monografia Basata su Evidenze
Product Description: Avana è un integratore alimentare a base di estratti standardizzati di Avena sativa (avena) e Withania somnifera (Ashwagandha), formulato per il supporto del sistema nervoso. È indicato per la gestione dei sintomi dello stress, dell’ansia lieve-moderata e per il miglioramento della qualità del sonno e della resilienza psicofisica. La sua azione si basa sul modulare i livelli di cortisolo e sull’interazione con i recettori del GABA, promuovendo uno stato di calma senza sedazione marcata.
Bottled Cialis: Significant Health Risks of Unregulated Tadalafil Products - Evidence-Based Review
Product Description The product in question, commonly referred to in informal channels as “Bottled Cialis,” is not a licensed pharmaceutical or a conventional dietary supplement. It represents a category of products that are marketed as containing Tadalafil, the active pharmaceutical ingredient in the prescription medication Cialis® (manufactured by Eli Lilly and Company). These products are typically sold online or in informal retail settings without a prescription, often in packaging that mimics or alludes to the authentic drug but lacks proper regulatory oversight, manufacturing standards, and consistent labeling.
Bottled Viagra: Natural Support for Erectile Function - Evidence-Based Review
Product Description The following monograph details the composition, mechanism, action, and clinical application of the dietary supplement commonly referred to in consumer and some professional circles as “Bottled Viagra.” It is critical to clarify from the outset that this is not a pharmaceutical drug, nor is it a generic or alternative form of sildenafil citrate (the active ingredient in Viagra®). “Bottled Viagra” is a colloquial marketing term used to describe a specific category of dietary supplements formulated with ingredients purported to support male sexual function, primarily erectile function, through vasodilation and nitric oxide pathway modulation.
Bottled Viagra: Nitric Oxide Support for Vascular and Erectile Health - Evidence-Based Review
Product Description & Clinical Context What we’re discussing here isn’t the pharmaceutical sildenafil, but a colloquial term that’s cropped up in practice: “Bottled Viagra.” It refers to a specific, high-concentration liquid L-citrulline malate supplement. I know, the name is problematic—it’s reductive and frankly, marketing-driven—but it’s entered the lexicon. Patients come in asking about it after hearing it on podcasts or from friends, so we need to address it directly. In my urology and men’s health clinic, I started seeing this trend about three years ago.
Caverta
Let’s talk about Caverta. In the clinic, when a patient presents with erectile dysfunction (ED), it’s rarely just a standalone issue. It’s a window into vascular health, psychological well-being, and often, a complicating factor in relationships. For years, the introduction of sildenafil citrate revolutionized our approach, moving from invasive interventions to a pill. Caverta is one of the key generic formulations of this molecule I’ve worked with extensively. It’s not a magic bullet, but when used correctly, within the right clinical context, it’s a profoundly effective tool.
Cenforce
Let’s talk about Cenforce. In my practice, it’s one of those names that comes up constantly, not just from patients but from colleagues trying to navigate the crowded landscape of phosphodiesterase type 5 (PDE5) inhibitors. It’s not a novel compound—we all know it’s sildenafil citrate, the same active ingredient as in the original Viagra—but its prevalence as a generic and the sheer volume of patient questions about it demand a thorough, evidence-based breakdown.
Cenforce Professional
Product Monograph: Cenforce Professional Formula: Cenforce Professional: A Comprehensive Review for Erectile Dysfunction Management Let’s talk about Cenforce Professional. In my clinic, when a patient presents with erectile dysfunction (ED), the conversation has moved far beyond just writing a script. It’s about understanding pathophysiology, patient expectations, and selecting the right tool from the arsenal. Cenforce Professional, which is sildenafil citrate in a 100mg dose, is one of those fundamental tools. It’s not new—we’ve had sildenafil for over two decades—but its specific formulation as “Cenforce Professional” and its place in treatment algorithms warrants a clear, clinical deep-dive.
